Ask a digital health founder why last month's content didn't ship and the answer usually arrives with an apology attached. It's with me. I've had it since the 3rd.
That's the whole problem, and it has almost nothing to do with the writing.
At seed stage the founder is the only person in the building who knows which claims are safe, which pilot numbers can be quoted in public, and which clinician on the advisory board will wince at a particular sentence. So every draft routes through one inbox. And that inbox belongs to the person doing fundraising, sales calls, product decisions and the occasional support ticket.
Almost every draft that goes in comes back approved. The cost is the wait.
What review latency costs
Run the arithmetic once and it stops looking like an admin annoyance.
Say you've committed to 4 pieces a month. Writing takes 5 working days. Review takes 30 minutes of real reading, but it sits for 9 days before it gets those 30 minutes, then comes back with one open question that takes another 4 days to close.
You're now publishing 4 pieces every 7 weeks against a plan that assumed 4 every 4. Over a year that's roughly 27 pieces live instead of 48.
Those 21 missing pieces are the smaller loss.
In a category Google treats as Your Money or Your Life, a new page needs two quarters or more before it holds a position worth anything. A piece delayed 6 weeks starts its ranking clock 6 weeks late, and every downstream piece that would have linked to it starts late too. Slippage in month 2 shows up as flat traffic in month 8, long after anyone connects the two.
Meanwhile the founder's calendar is the least elastic resource in the company. Any content process built on the assumption that it will loosen up next month is a process that fails slowly and quietly.
You're doing two jobs in one pass
Watch a founder review a draft and you can see two separate checks running at the same time.
The first is accuracy. Is the claim defensible, is that number from the right cohort, would a clinician or a regulator push back on the phrasing.
The second is voice. Does this sound like me, would I say it that way in front of an advisor.
Only one of those has to sit with you personally, every time.
The accuracy check needs someone with clinical and regulatory judgment. That's often the founder, and often the clinical advisor who's already on the cap table and would answer in an hour if asked properly. The voice check does need the founder, and it should cost 10 minutes rather than 10 days.
Pulling those two apart is where most of the lost time comes back.
Answer each question once
The biggest source of repeat review is the same question arriving in a slightly different sentence.
Can we say the pilot cut missed appointments? Can we name the trust or the health system? Do we describe the product as a diagnostic or as decision support? Is the founder a clinician or a former clinician?
Most founders answer these one draft at a time, forever.
The fix is a claims file. One document, owned by you, updated whenever a new question comes up. Four columns cover it:
- The claim, written exactly as it can appear in public
- Its status: approved, approved with conditions, or off limits
- The source, cohort or document behind it
- The date it was last checked
The conditions column is the one that earns its keep. "Reduced missed appointments by 22%" might be approved on condition the 9-site pilot size appears in the same sentence. "Clinically validated" might be off limits until a specific paper publishes. "Built by clinicians" might be fine as long as it sits next to your registration.
Thirty lines takes an afternoon to write and removes most of what turns a 30-minute review into a 3-week thread. It's also the first document your first marketing hire will ask for, and one an investor's diligence process is glad to find already sitting there.
Hand the accuracy check to your advisor properly
Clinical advisors are usually willing to review content. They're rarely asked in a way they can act on.
"Can you take a look at this when you get a minute?" comes back in 2 weeks, if at all. A closed question comes back the same day.
Send the draft with 2 questions attached, both answerable in a line:
- Is the mechanism described correctly in the section marked?
- Is there anything here a clinician in this specialty would dispute?
Then attach a deadline you're genuinely willing to publish past. If nothing comes back in 3 working days, the piece goes out with the clinical claim removed rather than waiting.
That last part is what makes the whole thing work. A review step with no expiry date is a queue with a polite name.
Regulatory language deserves its own 20 minutes
There's usually one claim in a digital health founder's head that feels risky enough to freeze the whole piece. Something near the line between a wellness tool and a regulated medical device, or a phrase that edges toward diagnosis.
That claim needs one conversation with someone qualified, once, and then an entry in the claims file that settles it for every piece written afterwards.
Founders tend to defer that conversation because it feels like a big piece of work. In practice it's a 20-minute call with your regulatory adviser and a list of 6 phrasings you'd like to use. Most come back approved with a small wording change. The 1 that doesn't is worth knowing about before it's in a published article rather than after.
Leave it unresolved and every writer, every month, drafts around a boundary that was never drawn. You get vague copy, and vague copy in digital health reads as evasive to exactly the clinical audience you need.
Move your attention to the outline
Founder review usually lands at the worst possible point in the process, which is after the piece is fully written. By then a wrong angle costs a rewrite.
Put your attention on the outline instead. Fifteen minutes on a structure with the claims marked, before a word of the draft exists, catches the 4 problems that actually cause rewrites: wrong audience, wrong claim, wrong angle for where the market is right now, wrong week to publish it.
Then the draft review becomes a single pass with one rule: comments on accuracy and voice only. Line edits go to the writer untouched.
Founders rewrite sentences because they can, and every rewritten sentence adds a round trip. If your edits are consistently rewriting the writing itself, that's a brief problem or a writer problem, and it should be fixed at that level instead of absorbed with founder hours every single month.
What a workflow that survives a bad month looks like
Four fixed points, and nothing else:
- A 20-minute recorded call at the start of the month where you talk through the angles out loud. That recording is the raw material for every brief.
- Outlines approved in writing inside 48 hours, or they proceed as written.
- Drafts reviewed in one pass, accuracy and voice only, inside 3 working days.
- A claims file that absorbs every new answer so the same question is never asked twice.
All of it fits on one page and runs without a marketing hire or a new tool. The hard part is a single decision: content ships on a schedule, and your own review step is subject to that schedule like everything else in the company.
The 48-hour and 3-day defaults are the load-bearing parts. Without them you've written down the same queue you already have.
Who holds the publish button
One more thing has to move, and founders resist it hardest.
Someone other than you needs the ability to publish. As long as the final click sits with the founder, every deadline in the workflow above is advisory, and the queue quietly reassembles itself within a month.
That's less risky than it sounds once the claims file exists, because the person publishing is only ever checking a finished piece against a document you wrote. If a sentence isn't covered by the file, it waits until you've answered, and your answer gets added to the file.
Two people can run this: whoever writes, and whoever owns the site. At 15 employees that's often the same person, and it still works, because the constraint being removed is your attention rather than headcount.
Where this shows up in pipeline
A clinical director evaluating your platform forms her opinion from what's published on the day she looks you up. Drafts in your inbox aren't part of that opinion. Neither is the piece scheduled for next month.
Same for the associate at the fund who reads your archive before the partner meeting. What she's reading for is a pattern: dated pieces, published steadily, about work that was live at the time. A publishing gap between March and July says something about how the company runs, and it says it before you get to explain that the writing was done, it was just waiting.
Speed here compounds in a way most seed-stage marketing spend doesn't. Every week a piece sits unpublished is a week it isn't ranking, isn't being forwarded by an advisor, and isn't doing the trust work that makes your next sales call shorter.
If you want a rough diagnostic, open the folder where your drafts live and check the date on the oldest unpublished one. If it's more than 3 weeks old, writing isn't your constraint.
Fix the review step first. It's a lot cheaper than hiring anyone.